Other
Periodontal Disease
0
Pipeline Programs↗
9
Active Trials↗
1
Companies Involved↗
Periodontal Disease is an early-stage landscape with 0 programs across 1 company. The most active players are Eli Lilly.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
20
clinical trials
Completed10 · 50%
Recruiting5 · 25%
Not yet recruiting4 · 20%
Unknown status1 · 5%
Clinical Trials
Trial Activity
20 trials
Periodontal Inflammation in Rare Renal Disorders - A Cross-Sectional Controlled Observational Study Assessing the Burden and Phenotypes of Periodontal Disease
Recruiting·—·N/A·NCT07575347·100 enrolled
Clinical Investigation of the Effects of Colgate Total Toothpaste as Compared to a Matching Placebo on Periodontal Disease and Systemic Inflammatory Markers
Completed·—·Phase 4·NCT02670135·303 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)